Leiden Academic Centre for Drug Research
The Leiden Academic Centre for Drug Research (LACDR) is a centre of excellence for multidisciplinary research on drug discovery and development.
Despite major advances in medicine- research, many common diseases such as cancers, neurological or cardiovascular diseases, or auto-immune diseases, still lack effective treatment, or are still often found incurable.
That is why our work to develop new and more effective drugs is essential. At the LACDR we work at the leading edge of drug-design and fundamental research of new drugs, optimization of existing drugs, and personalised medicine.
Our research is focused in three clusters: Drug and Target Discovery, Bio-Therapeutics and Systems Pharmacology, which you can find below:
Combining the expertises of Biopharmaceutics and Drug Delivery Technology. Our research-focus lies on advancing innovative biopharmaceutical concepts to intervene in auto-immune-like disorders.
Drug & Target Discovery
Incorporating the strengths of Toxicology and Medicinal Chemistry we focus on advanced imaging-based phenotypic screening for drug target and drug lead discovery.
Conjoining the fields of Pharmacology and Analytical Biosciences our research focusses on personalised medicine and the development of novel systems-based approaches in translational and clinical pharmacology.
Education in Biopharmaceutical Sciences
Our education ranges the Bachelor's and Master's programs in Bio-Pharmaceutical Sciences and the LACDR PhD program. We are committed to providing quality graduate experiences in a personalized environment of cutting edge research and internationally renowned supervisors.
Events07FebPhD Defence Pulling the strings on anti-cancer immunityK. Kersten09FebPhD Defence Transforming Data into Knowledge for Intelligent Decision-making in Early Drug DiscoveryShardul Paricharak23FebPhD Defence Supercritical carbon dioxide spray drying for the production of stable dried protein formulationsO. Nuchuchua